| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $744.7M | — | +5.5% |
| Cost of Revenue | $192.2M | — | -2.6% |
| R&D Expense | $98.0M | — | -5.6% |
| SG&A Expense | $143.5M | — | +120.1% |
| Operating Income | -$49.6M | — | -173.2% |
| Pre-tax Income | -$73.8M | — | -279.6% |
| Income Tax | -$16.3M | — | -255.2% |
| Net Income | -$57.5M | — | -287.9% |
| EPS (Basic) | -$0.15 | — | -287.5% |
| EPS (Diluted) | -$0.15 | — | -287.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $779.2M | +13.9% | +79.2% |
| Accounts Receivable | $180.0M | +11.2% | -6.6% |
| Current Assets | $1.07B | +0.5% | +29.1% |
| Total Assets | $3.69B | -0.9% | +3.1% |
| Current Liabilities | $904.1M | -6.6% | +97.3% |
| Long-term Debt | $2.39B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $22.8M | — | +21.3% |
| Capital Expenditures | $5.7M | — | -45.2% |
| Investing Cash Flow | $115.5M | — | +209.9% |
| Financing Cash Flow | -$43.6M | — | +8.0% |
| Free Cash Flow | $17.1M | — | +103.6% |
| -0.4% |
| Total Liabilities | $4.15B | +0.5% | +12.4% |
| Stockholders' Equity | -$463.1M | -12.6% | -295.1% |